Navigation Links
Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
Date:5/23/2013

TOKIO, 22. Mai 2013 /PRNewswire/ -- Ranbaxy Laboratories Limited (im Weiteren Ranbaxy), eine Tochtergesellschaft von Daiichi Sankyo Co., Ltd. (im Weiteren Daiichi Sankyo), gab am 22. Mai die Maßnahmen bekannt, die Ranbaxy in den letzten Jahren ergriffen hat, um sich der Angelegenheiten der vorhergehenden Unternehmensführung anzunehmen.

(http://www.daiichisankyo.com/media_investors/media_relations/press_releases/index.html).

Daiichi Sankyo unterstützt Ranbaxy weiterhin dabei, die Fehler der vorhergehenden Geschäftsführung zu korrigieren, welche zu Untersuchungen durch das Justizministerium der Vereinigten Staaten und die US-Arzneimittelzulassungsbehörde („USFDA") geführt hatten. Die Änderungen, die bei Ranbaxy vorgenommen werden sollen, umfassen die Geschäftsführung, die Unternehmenskultur, den Betrieb und die Compliance.

Daiichi Sankyo geht davon aus, dass bestimmte ehemalige Aktionäre von Ranbaxy wichtige Informationen hinsichtlich der Untersuchungen durch das US-Justizministerium und die FDA verschwiegen und falsch dargestellt haben. Daiichi Sankyo prüft derzeit die verfügbaren Rechtsmittel und kann das Thema nicht weiter kommentieren.

Informationen zu Daiichi Sankyo Co., Ltd. 
Börsennotierung: Börsenkürzel: 4568, Erster Index der Börsen in Tokio, Osaka und Nagoya
Präsident und CEO: Joji Nakayama

Kontakt: 
Noriaki Ishida 
Corporate Officer & Vice President 
Abteilung für Unternehmenskommunikation
Daiichi Sankyo Co., Ltd. 
Tel.: +81-3-6225-1126 
E-Mail: kondo.toshiya.cj@daiichisankyo.co.jp

http://www.daiichisankyo.com/


'/>"/>
SOURCE Daiichi Sankyo Co., Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA
2. Ranbaxy Commends New IMS Study Which Credits Generic Prescription Drugs With $1 Trillion Savings In U.S. Health Care Costs Over Past 10 Years
3. Ranbaxy Launches Authorized Generic Of Pioglitazone In The U.S.
4. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
5. Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.
6. Indias Largest Generic Drugmaker Ranbaxy Pays $500 Million to Settle Systemic Generic Drug Manufacturing Fraud
7. Statement By Dinesh Thakur Regarding US Governments Case Against Ranbaxy
8. Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives
9. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
10. Simbionix kündigt Lizenzvertrag für chirurgische Videos an
11. Blue Belt Technologies kündigt Gründung eines wissenschaftlichen Beirats für Hüfteingriffe zur Bestimmung neuer Anwendungsgebiete von NavioPFS bei femoro-acetabulärem Impingement an
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals plc ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, ... of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ... (Eastern Daylight Time). As previously announced on ... a definitive merger agreement under which Jazz Pharmaceuticals has ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
Breaking Medicine News(10 mins):